Hair Loss Treatment Using Erbium:YAG Fractional Laser with Hair Growth-promoting Solution
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Several methods have been used to treat androgenetic hair loss, ranging from hair transplants to finasteride and minoxidil. Sometimes plateletrich plasma injection therapy may be used to increase the satisfaction of patients who come to the hospital. However, some patients are sensitive to pain and are subjected to the inconvenience of requiring treatment after each blood sampling. The author had reported the effects of using a hair growth-promoting solution and JetpeelTM in parallel with a painless hair loss treatment method. However, the author was interested in more effective methods for patients with M-shaped or vertex hair loss who do not want to take medications or undergo hair transplant. In addition to the existing light-emitting diode therapy and electromagnetic field treatment, the author has made considered attempts to use various laser wavelength bands. However, the equipment for these methods can be expensive and are not suitable for patients who emphasize on costeffectiveness. Therefore, the author used an existing reported method and a device based on the fractional erbium:YAG laser to provide the hair growth-promoting solution in parallel. The author chose a fractional 2940 nm-based laser device as a medium that could efficiently increase the growth phase, reduce the catagen phase, and facilitate intradermal product and drug delivery. As a result, there was a therapeutic benefit without any significant side effects such as redness and itching. Among the patients, the author reported the effects of the treatment on one patient with frontal M-shaped, mid, and vertex hair loss.
Abstract
Several methods have been used to treat androgenetic hair loss, ranging from hair transplants to finasteride and minoxidil. Sometimes plateletrich plasma injection therapy may be used to increase the satisfaction of patients who come to the hospital. However, some patients are sensitive to pain and are subjected to the inconvenience of requiring treatment after each blood sampling. The author had reported the effects of using a hair growth-promoting solution and JetpeelTM in parallel with a painless hair loss treatment method. However, the author was interested in more effective methods for patients with M-shaped or vertex hair loss who do not want to take medications or undergo hair transplant. In addition to the existing light-emitting diode therapy and electromagnetic field treatment, the author has made considered attempts to use various laser wavelength bands. However, the equipment for these methods can be expensive and are not suitable for patients who emphasize on costeffectiveness. Therefore, the author used an existing reported method and a device based on the fractional erbium:YAG laser to provide the hair growth-promoting solution in parallel. The author chose a fractional 2940 nm-based laser device as a medium that could efficiently increase the growth phase, reduce the catagen phase, and facilitate intradermal product and drug delivery. As a result, there was a therapeutic benefit without any significant side effects such as redness and itching. Among the patients, the author reported the effects of the treatment on one patient with frontal M-shaped, mid, and vertex hair loss.
참고문헌 (12)
- Perper M, "Efficacy of fractional lasers in treating alopecia : a literature review", Lasers Med Sci, 32, pp.1919~1925 (2017)
- Ke J, "Erbium : YAG laser(2, 940nm)treatment stimulates hair growth through upregulating Wnt 10b and β-catenin expression in C57BL", 6 mice, 2015, pp.8, 20883~20889
- Cho S, "Clinical effects of non-ablative and ablative fractional lasers on various hair disorders : a case series of 17 patients", J Cosmet Laser Ther, 15, pp.74~79 (2013)
- Lin CH, "Lasers as an approach for promoting drug delivery via skin", Expert Opin Drug Deliv, 11, pp.599~614 (2014)
- Gou S, "Er : YAG fractional laser ablation for cutaneous co-delivery of pentoxifylline and d-α-tocopherol succinate : a new approach for topical treatment of radiation-induced skin fibrosis", Eur J Pharm Sci, 135, pp.22~31 (2019)
- Yu J, "Needle-free cutaneous delivery of living human cells by Er : YAG fractional laser ablation", Expert Opin Drug Deliv, 15, pp.559~566 (2018)
- Bachhav YG, "Controlled intra-and transdermal protein delivery using a minimally invasive Erbium : YAG fractional laser ablation technology", Eur J Pharm Biopharm, 84, pp.355~364 (2013)
- Song Y, "Transdermal delivery of human growth hormone via laser-generated micropores", Drug Deliv Transl Res, 8, pp.450~460 (2018)
- Ahn DH, "Transdermal delivery of a new hair growth promoting solution in patients with hair loss", Int J Case Rep Images, 10 (2019)[DOI]
- Parhi R, "Enhancement of skin permeability with thermal ablation techniques : concept to commercial products", Drug Deliv Transl Res, 11, pp.817~841 (2021)
- Gentile P, "Advances in regenerative stem cell therapy in androgenic alopecia and hair loss : Wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development", Cells, 8, pp.466~ (2019)
- Li Z, "Concentrated nanofat : a modified fat extraction promotes hair growth in mice via the stem cells and extracellular matrix components interaction", Ann Transl Med, 8, pp.1184~ (2020)